Peer-reviewedLicence not statedLancet Oncology
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
Related
- Efficacy and safety of first- versus second-generation fibroblast growth factor receptor (FGFR) inhibitors in advanced or metastatic urothelial carcinoma with FGFR alterations: a systematic review and meta-analysis
- Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling
- Bedside Bioimpedance and Simple Functional Tests Identify Muscle Function Impairment Predicting Overall Survival in Chemotherapy-treated Metastatic Urothelial Carcinoma: A Retrospective Pilot Study
- Opposing Natural Killer and Macrophage Associations Are Masked Within a CD16/IL-15/IL-15RA Composite Score in Metastatic Urothelial Carcinoma
- Changes in Treatment Patterns and Survival Outcomes Across Therapeutic Eras in Metastatic Urothelial Carcinoma: A Multicenter Real-World Study.
BibTeX
@article{siefkerradtke2026efficacy,
title = {{Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study}},
author = {Arlene Siefker-Radtke and Andrea Necchi and Se Hoon Park and Jesús García-Donas and Robert Huddart and Earle Burgess and Mark Fleming and Arash Rezazadeh Kalebasty and Begoña Mellado and Sergei Varlamov and Monika Joshi and Ignacio Duran and Scott Tagawa and Yousef Zakharia and Sydney Akapame and Ademi Santiago-Walker and Manish Monga and Anne O'Hagan and Yohann Loriot and Andrea Necchi and Yohann Loriot and Se Hoon Park and Scott Tagawa and Aude Flechon and Boris Alexeev and Sergey Varlamov and Robert Huddart and Earle Burgess and Arash Rezazadeh and Arlene Siefker-Radtke and Yann Vano and Donatello Gasparro and Alketa Hamzaj and Eugeniy Kopyltsov and Jesus Gracia Donas and Begona Mellado and Omi Parikh and Peter Schatteman and Stephane Culine and Nadine Houédé and Sylvie Zanetta and Gaetano Facchini and Giorgio Scagliotti and Giovanni Schinzari and Jae Lyun Lee and Mikhail Shkolnik and Mark Fleming and Monica Joshi and Peter O'Donnell and Herbert Stöger and Karel Decaestecker and Luc Dirix and Jean Pascal Machiels and Dephine Borchiellini and Remy Delva and Frederic Rolland and Boris Hadaschik and Margitta Retz and Eli Rosenbaum and Umberto Basso},
journal = {Lancet Oncology},
year = {2026},
month = sep,
doi = {10.1016/s1470-2045(21)00660-4},
url = {https://hal.science/hal-05744041v1},
}
RIS
TY - JOUR
TI - Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
AU - Arlene Siefker-Radtke
AU - Andrea Necchi
AU - Se Hoon Park
AU - Jesús García-Donas
AU - Robert Huddart
AU - Earle Burgess
AU - Mark Fleming
AU - Arash Rezazadeh Kalebasty
AU - Begoña Mellado
AU - Sergei Varlamov
AU - Monika Joshi
AU - Ignacio Duran
AU - Scott Tagawa
AU - Yousef Zakharia
AU - Sydney Akapame
AU - Ademi Santiago-Walker
AU - Manish Monga
AU - Anne O'Hagan
AU - Yohann Loriot
AU - Andrea Necchi
AU - Yohann Loriot
AU - Se Hoon Park
AU - Scott Tagawa
AU - Aude Flechon
AU - Boris Alexeev
AU - Sergey Varlamov
AU - Robert Huddart
AU - Earle Burgess
AU - Arash Rezazadeh
AU - Arlene Siefker-Radtke
AU - Yann Vano
AU - Donatello Gasparro
AU - Alketa Hamzaj
AU - Eugeniy Kopyltsov
AU - Jesus Gracia Donas
AU - Begona Mellado
AU - Omi Parikh
AU - Peter Schatteman
AU - Stephane Culine
AU - Nadine Houédé
AU - Sylvie Zanetta
AU - Gaetano Facchini
AU - Giorgio Scagliotti
AU - Giovanni Schinzari
AU - Jae Lyun Lee
AU - Mikhail Shkolnik
AU - Mark Fleming
AU - Monica Joshi
AU - Peter O'Donnell
AU - Herbert Stöger
AU - Karel Decaestecker
AU - Luc Dirix
AU - Jean Pascal Machiels
AU - Dephine Borchiellini
AU - Remy Delva
AU - Frederic Rolland
AU - Boris Hadaschik
AU - Margitta Retz
AU - Eli Rosenbaum
AU - Umberto Basso
PY - 2026
DA - 2026/09/09
JO - Lancet Oncology
DO - 10.1016/s1470-2045(21)00660-4
UR - https://hal.science/hal-05744041v1
SN - 1470-2045
SN - 1474-5488
ER -